Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    • News

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

  • Medibank Backs Emyria with Landmark Depression Care Deal
    Medibank Backs Emyria with Landmark Depression Care Deal
    • News

  • NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    • News

  • BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    • News

  • Harris Technology eyes profitability as refurbished tech sales surge
    Harris Technology eyes profitability as refurbished tech sales surge
    • News

  • QIC Fund Backs Ark Mines with $4.5m to Accelerate Sandy Mitchell Development
    • News

  • Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    • News

  • FBR’s tech could help reduce housing construction-related cost pressures
    FBR’s tech could help reduce housing construction-related cost pressures
    • News

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

Healthia exceeds Prospectus forecasts in maiden FY earnings

  • In News
  • August 31, 2019
  • Alfred Chan
Healthia exceeds Prospectus forecasts in maiden FY earnings

National healthcare provider Healthia Ltd (ASX: HLA) has released its maiden FY earnings report with the Company delivering pro-forma EBITDA of $11.7 million*, exceeding forecasts by 13.6%.

Since listing on the ASX in September 2018 under the guidance of Chairman Glen Richards, Healthia has increased their national presence through the continued acquisition of allied health clinics, now with 133 under their banner, up from 104 at their time of listing.

“FY19 was the foundation year for Healthia which saw our time and effort spent on the integration of our existing, and newly acquired, clinics,” said Richards.

“We can now look forward with confidence that we have built a strong foundation to acquire further quality businesses and continue to evolve our corporate support to ensure optimal workplaces for our growing network of clinicians which helps us to deliver exceptional patient outcomes.”

Other key highlights from the results were a rise on revenue forecasts by 6.6% and rise in NPAT forecasts by 2.2%, the latter impacted by one-off acquisition and clinic integration costs.

Key to the growth in earnings has been a $37m loan facility which enabled the Company to target new podiatry and physiotherapy clinics. Healthia intends to deploy a further $15m in FY20 to continue growing their network of allied health clinics.

Under the company’s vertically integrated model, clinicians joining the Healthia structure gain access to corporate support as well supply chain benefits via 3D printed orthotics manufacturer iOthotics and DBS Medical supplies – both brands owned under the Healthia banner.

With a growing network of clinicians joining the business, Healthia is in the process of expanding their graduate program which last year had an intake of 33 graduates, and in October will host their inaugural 2-day Integrated Health Conference on the Gold Coast.

Prior to spearheading the Healthia IPO, Glen Richards founded Greencross Vets, Petbarn and City Farmers which were sold to U.S private equity firm TPG Capital for $675m in February 2019. He has also appeared as a panellist on Shark Tank since 2016 where he continues to promote entrepreneurship and innovation as an active investor.

Richards is the largest Healthia shareholder.

Investors and analysts are welcome to subscribe to the Healthia mailing list to receive Company news and industry research.

* Pro-forma results are presented as they reflect the underlying performance of the business by assuming all acquisitions made during the year completed on 1 July 2018. An adjustment has also been made for the one-off cost associated with the IPO, acquisitions, integration and restructure costs

**Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  •  
  •  
  •  
  •  
  • Glen Richards
  • Greenscross
  • healthcare
  • healthia
  • HLA
  • iOrthotics
  • Petbarn
  • Shark Tank
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alfred Chan
Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.
Latest posts by Alfred Chan (see all)
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians - April 30, 2025
  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium - March 10, 2025
  • ARC Funds acquires 30% of auzbiz Capital as latest direct-to-investor marketing venture - October 8, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.